This study was performed to investigate the pharmacokinetics ( PK ) , pharmacodynamics ( PD ) , and tolerability of GCPGC , a new formulation of pegylated G-CSF , in healthy volunteers and to compare them with those of pegfilgrastim ( Neulasta ) .